70 results
8-K
EX-10.1
ORIC
ORIC Pharmaceuticals Inc
29 Mar 24
Departure of Directors or Certain Officers
4:15pm
in good faith by the Administrator.
The determination of fair market value for purposes of tax withholding may be made in the Administrator’s discretion … or to satisfy the tax withholding obligations related to an Award will become available for future grant or sale under the Plan. To the extent an Award under
S-3ASR
EX-4.2
ORIC
ORIC Pharmaceuticals Inc
11 Mar 24
Automatic shelf registration
5:28pm
or exchange (except as otherwise expressly permitted herein), but the Company may require payment of a sum sufficient to cover any transfer tax … or similar governmental charge payable in connection therewith (other than any such transfer tax or similar governmental charge payable upon exchanges pursuant
S-3ASR
3flzsxcvw
11 Mar 24
Automatic shelf registration
5:28pm
8-K
EX-10.1
3tr2g1wv
22 Jan 24
ORIC Pharmaceuticals Announces $125 Million Private Placement Financing
9:01am
S-3
yj25fgqtm g4r
15 Dec 23
Shelf registration
4:32pm
8-K
EX-4.1
otgacyt91fsurq4sr 5n
27 Jun 23
ORIC Pharmaceuticals Announces $85 Million Private Placement Financing
6:05am
8-K
EX-10.1
vunh700
27 Jun 23
ORIC Pharmaceuticals Announces $85 Million Private Placement Financing
6:05am
8-K
EX-99.2
ez6j1ex0g0rey7suj
21 Dec 22
Other Events
5:25pm
424B5
1shz2mmxrx4 apunqy0q
21 Dec 22
Prospectus supplement for primary offering
5:23pm